SCHEMBL9896760

SCHEMBL9896760

COC(=O)c1cc(O)c2ccc(OC)cc2c1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.53
MAPK8 P45983 2/20 0.51
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C19 P33261 2/20 0.47
KDM4E B2RXH2 2/20 0.47
CYP2C9 P11712 1/20 0.47
GABRA1 P14867 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA5 P31644 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
NR4A2 P43354 3/20 0.44
EGFR P00533 1/20 0.44
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
PGR P06401 1/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899175 0.90 SMN1; SMN2 (0.47) PLA2G2AMAPK8CYP1A2CYP2D6CYP2C19
SCHEMBL9898507 0.87 NR4A2 (0.50) MAPK8KDM4ENR4A2EGFRALDH1A1
SCHEMBL6170807 0.84 LMNA (0.50) MAPK8KDM4ENR4A2EGFRALDH1A1
SCHEMBL9899615 0.83 PLA2G2A (0.49) PLA2G2AMAPK8CYP1A2CYP2D6CYP2C19
SCHEMBL30128969 0.82 DHODH (0.46) PLA2G2AKDM4ENR4A2EGFRALDH1A1
SCHEMBL17733182 0.82 FABP3 (0.47) PLA2G2AMAPK8CYP1A2CYP2D6CYP2C19
SCHEMBL1334120 0.82 DHODH (0.46) PLA2G2AKDM4ENR4A2EGFRALDH1A1
SCHEMBL6169484 0.80 PLA2G2A (0.43) PLA2G2AMAPK8GABRA1GABRG2GABRB3
SCHEMBL1514525 0.80 GPR35 (0.50) KDM4EALDH1A1LMNAHPGDDHODH
SCHEMBL8510685 0.78 PLA2G2A (0.51) PLA2G2AMAPK8CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 US disclosed
WO-2013086248-A1 PHOTOCHROMIC MATERIALS THAT INCLUDE INDENO-FUSED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 2013-06-13 WO disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans NQO1, INTS6, IPO4 PLA2G2A 1829/4885MAPK8 2332/4885CYP1A2 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.